Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00851396 · ClinicalTrials.gov registry record
Assessment of Influence of Vitamin D on Insulin Secretion and Sensitivity in Obese Teenage Girls
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 30
- Enrollment target
NCT00851396: Completed study, sponsored by University of Alabama at Birmingham.
NCT00851396 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00851396 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the relationship between vitamin D status and insulin- glucose dynamics in obese Adolescents. The study is intended to assess the difference in the insulin sensitivity before and after correction of vitamin D deficiency.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-10 |
What the finished NCT00851396 record still lists
NCT00851396 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00851396 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00851396 about?
NCT00851396 is a clinical study titled "Assessment of Influence of Vitamin D on Insulin Secretion and Sensitivity in Obese Teenage Girls". The purpose of the study is to assess the relationship between vitamin D status and insulin- glucose dynamics in obese Adolescents. The study is intended to assess the difference in the insulin sensitivity before and after correction of vitamin D deficiency.
What is the current status of trial NCT00851396?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2008-04. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT00851396?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia